Pierre-Alain Ruffieux of Cytiva discusses key biotech trends including new modalities, AI adoption, supply chain stability, ...

Collaboration combines Nuclera’s eProtein Discovery System, which accelerates protein expression, purification and optimization, with Cytiva’s Biacore SPR system, which characterizes molecular ...

Biopharma’s ongoing quest to develop COVID-19 drugs and vaccines, plus growing industry demand for producing various types of new therapies, are fueling the $1.5-billion expansion of manufacturing ...

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities. Cytiva has acquired CEVEC Pharmaceuticals, a Germany-based provider of ...

Pierre-Alain Ruffieux, Cytiva’s group executive, bioprocess, discusses completion of the doubling of the company’s liquid ...

BOSTON, June 15, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences and Cytiva are collaborating to advance innovation in upstream bioprocessing by providing customers greater access to predictive and ...

Cytiva, a Massachusetts-based research and biopharma manufacturing specialist, has opened the doors to its production facility in Cardiff, Wales. The 11,000-square-meter Welsh facility is already ...

Cytiva needed to expand its clean room capabilities to install additional and updated liquid pharmaceutical formulation and bottling equipment, which involved a new stand-alone structure on the Cytiva ...

The Xcellerex magnetic mixer, single-use mixing system was designed to address challenges in large-scale mAb, vaccine, and genomic medicine manufacturing processes. Cytiva unveiled the Xcellerex ...

Now offering Cytiva Diagnostic Services, new diagnostic test development and support service virtually or at new lab, for point-of-care diagnostic developers to increase speed to market of new tests.

Quick ReadDanaher (DHR) locks biopharma customers into Cytiva's workflows through astronomical switching costs, turning over 70% of revenue into predictable, recurring income.Free cash flow hit $5.26 ...

Cambridge, UK and Marlborough, MA, 28 May 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a ...